Insider Trading disclosures for LivaNova PLC

The latest disclosure was made by Michael David Hutchinson in LivaNova PLC where a trade of 2,254 Restricted Stock Units done was reported to US exchanges on Dec. 15, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Michael David Hutchinson	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	2,254	4,507	-		-	Restricted Stock Units
Michael David Hutchinson	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	2,254	4,540 (0%)	0%		0	Ordinary Shares
Michael David Hutchinson	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.50 per share.	15 Dec 2024	784	3,756 (0%)	0%	51.5	40,376	Ordinary Shares
Susan M. Podlogar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2024	2,355	2,355	-		-	Restricted Stock Units
James Christopher Barry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	1,709	0	-		-	Restricted Stock Units
James Christopher Barry	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.50 per share.	15 Dec 2024	353	1,356 (0%)	0%	51.5	18,180	Ordinary Shares
James Christopher Barry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	1,709	1,709 (0%)	0%		0	Ordinary Shares
Alex Shvartsburg	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	613	0	-		-	Restricted Stock Units
Alex Shvartsburg	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	613	19,342 (0%)	0%		0	Ordinary Shares
Alex Shvartsburg	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.50 per share.	15 Dec 2024	229	19,113 (0%)	0%	51.5	11,794	Ordinary Shares
Franco Poletti	President, Cardiopulmonary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.50 per share.	15 Dec 2024	416	7,218 (0%)	0%	51.5	21,424	Ordinary Shares
Franco Poletti	President, Cardiopulmonary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	967	7,634 (0%)	0%		0	Ordinary Shares
Franco Poletti	President, Cardiopulmonary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2024	967	967	-		-	Restricted Stock Units
Francesco Bianchi	Director	Sale of securities on an exchange or to another person at price $ 50.99 per share.	11 Dec 2024	1,250	7,522 (0%)	0%	51.0	63,738	Ordinary Shares
Franco Poletti	President, Cardiopulmonary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2024	5,885	5,885	-		-	Stock Appreciation Rights
Franco Poletti	President, Cardiopulmonary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2024	2,575	2,575	-		-	Restricted Stock Units
Franco Poletti	President, Cardiopulmonary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2024	1,287	1,287	-		-	Performance Stock Units
Franco Poletti	President, Cardiopulmonary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2024	1,287	1,287	-		-	Performance Stock Units
Franco Poletti	President, Cardiopulmonary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2024	2,575	2,575	-		-	Performance Stock Units
Francesco Bianchi	Director	Sale of securities on an exchange or to another person at price $ 46.58 per share.	11 Sep 2024	1,500	8,772 (0%)	0%	46.6	69,870	Ordinary Shares
Peter M. Wilver	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Peter M. Wilver	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	4,317 (0%)	0%		0	Ordinary Shares
Peter M. Wilver	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	585	3,732 (0%)	0%	52.7	30,818	Ordinary Shares
Peter M. Wilver	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
William A. Kozy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	4,840	4,840	-		-	Restricted Stock Units
Todd C. Schermerhorn	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	586	6,057 (0%)	0%	52.7	30,870	Ordinary Shares
Todd C. Schermerhorn	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	6,643 (0%)	0%		0	Ordinary Shares
Todd C. Schermerhorn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Todd C. Schermerhorn	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
Stacy Enxing Seng	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	9,330 (0%)	0%		0	Ordinary Shares
Stacy Enxing Seng	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Stacy Enxing Seng	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
Stacy Enxing Seng	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	585	8,745 (0%)	0%	52.7	30,818	Ordinary Shares
Sharon O'Kane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	10,754 (0%)	0%		0	Ordinary Shares
Sharon O'Kane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Sharon O'Kane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
Sharon O'Kane	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	1,260	9,494 (0%)	0%	52.7	66,377	Ordinary Shares
Francesco Bianchi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Francesco Bianchi	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	10,857 (0%)	0%		0	Ordinary Shares
Francesco Bianchi	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	585	10,272 (0%)	0%	52.7	30,818	Ordinary Shares
Francesco Bianchi	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
James Christopher Barry	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Alex Shvartsburg	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	1,576	19,399 (0%)	0%		0	Ordinary Shares
Alex Shvartsburg	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	1,576	0	-		-	Restricted Stock Units
Alex Shvartsburg	CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	670	18,729 (0%)	0%	52.7	35,296	Ordinary Shares
Brooke Story	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	4,060 (0%)	0%		0	Ordinary Shares
Brooke Story	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,416	3,416	-		-	Restricted Stock Units
Brooke Story	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2024	2,680	0	-		-	Restricted Stock Units
Brooke Story	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share.	15 Jun 2024	584	3,476 (0%)	0%	52.7	30,765	Ordinary Shares
Ahmet Tezel	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2024	3,559	3,559	-		-	Performance Stock Units

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

38.55% Fall from 52W High

Insider Trading disclosures for LivaNova PLC

The latest disclosure was made by Michael David Hutchinson in LivaNova PLC where a trade of 2,254 Restricted Stock Units done was reported to US exchanges on Dec. 15, 2024.

Screeners based on Insider Trading and SAST parameters